ライフサイエンスコーパス: African green monkey

1 zed but estrogen-replaced nonhuman primates (African green monkeys).

2 SFV serotype 3 (SFVagm-3), isolated from an African green monkey.

3 to dietary cholesterol, and less responsive African green monkeys.

4 V-1 and simian immunodeficiency viruses from African green monkeys.

5 from vervet, grivet, and tantalus species of African green monkeys.

6 ts implanted in the striatum of MPTP-treated African green monkeys.

7 ulated in the dorsal and ventral striatum of African green monkeys.

8 oost neutralization titers in RSV-preexposed African green monkeys.

9 vaccine candidates after a single passage in African green monkeys.

10 simian immunodeficiency virus infections of African Green Monkeys.

11 tion in both LDL receptor-deficient mice and African green monkeys.

12 cur among natural SIV variants isolated from African green monkeys.

13 DSS treatment of SIV-infected African green monkeys, a natural host species for SIV th

14 l administration to the respiratory tract of African green monkeys, a permissive primate host.

15 luding human A3C (hA3C), human A3DE (hA3DE), African green monkey A3F (agmA3F), and rhesus macaque A3

16 irus (SIV) Vif was shown to bind and degrade African green monkey A3G (agmA3G) and, unexpectedly, hum

17 Here, we report the DNA sequence of an African green monkey AAV integration site isolated from

18 G but not rhesus macaque APOBEC3G (rhA3G) or African green monkey (AGM) APOBEC3G (agmA3G) because of

19 veloped for studying HeV infection, with the African green monkey (AGM) appearing to most faithfully

20 The present report reveals that African green monkey (AGM) cells, which contain extensiv

21 l block within human cells that is absent in African green monkey (AGM) cells.

22 man APOBEC3G but does not block the mouse or African green monkey (AGM) enzyme.

23 , we examined the pathogenesis of HeV in the African green monkey (AGM) following intratracheal inocu

24 Here, an African green monkey (AGM) model was used to elucidate i

25 ddress this issue, we established a neonatal African green monkey (AGM) nonhuman primate model that c

26 Conversely, the Vif protein encoded by the African green monkey (agm) simian immunodeficiency virus

27 amics of the A3G-Vif interaction within four African green monkey (AGM) subspecies, which are each na

28 ort of endogenous retroviruses produced from African green monkey (AGM) tissues or cell lines.

29 function, we isolated cDNA clones of human, African green monkey (AGM), and NIH/Swiss mouse CCR5s, a

30 of SIVsab from its natural host, the sabaeus African green monkey (AGM), to a new host, the pigtailed

31 To investigate replication in primates, African green monkeys (AGM) and rhesus macaques (n = 4)

32 African green monkeys (AGM) and sooty mangabeys (SM) are

33 Natural hosts, such as African green monkeys (AGM) and sooty mangabeys (SM), ar

34 SIV) infection in its natural hosts, such as African green monkeys (AGM) and sooty mangabeys (SM).

35 African green monkeys (AGM) are natural hosts of simian

36 African green monkeys (AGM) are natural hosts of SIV, an

37 African green monkeys (AGM) do not develop overt signs o

38 d plasma were assessed in naturally infected African green monkeys (AGM) of the vervet subspecies (Ch

39 In contrast, both marmosets and African green monkeys (AGM) proved susceptible to aeroso

40 te pathogenic differences between strains, 4 African green monkeys (AGM) were exposed to NiVM and 4 A

41 onprogressive infection (SIVagm infection of African green monkeys (AGM)), and transient, controlled

42 ch as chimpanzees, sooty mangabeys (SM), and African green monkeys (AGM).

43 a wide range of African primates, including African green monkeys (AGM).

44 HIV-2 (EHO and ALI), and one strain of SIV (African Green Monkey, AGM).

45 their virulence in BALB/c mice, ferrets, and African green monkeys (AGMs) (Chlorocebus aethiops).

46 three viral pathogens in two populations of African green monkeys (AGMs) (Chlorocebus sabaeus) from

47 (PTMs) and in nonpathogenic SIV infection of African green monkeys (AGMs) and sooty mangabeys.

48 African green monkeys (AGMs) are a natural host of SIV t

49 lar, the geographically dispersed species of African green monkeys (AGMs) are all infected with highl

50 African green monkeys (AGMs) are natural hosts of simian

51 African green monkeys (AGMs) are natural primate hosts o

52 African green monkeys (AGMs) are naturally infected with

53 African green monkeys (AGMs) are naturally infected with

54 We used African green monkeys (AGMs) as a nonhuman primate (NHP)

55 reflect the findings in humans and evaluated African green monkeys (AGMs) as a nonhuman primate model

56 ous (approximately 98-99% identical) CCR5 of African green monkeys (AGMs) avidly binds beta-chemokine

57 To test the hypothesis that SIV-infected African green monkeys (AGMs) avoid AIDS due to virus rep

58 Chronically SIVagm-infected African green monkeys (AGMs) have a remarkably stable no

59 ble of eliciting a strong immune response in African green monkeys (AGMs) in a single dose.

60 c SIV infection in sooty mangabeys (SMs) and African green monkeys (AGMs) is associated with low leve

61 partments of chronically SIV-infected sabeus African green monkeys (AGMs) revealed that gastrointesti

62 collected from pigtailed macaques (PTMs) and African green monkeys (AGMs) that experience different S

63 ansmitted SIVsab from the sabaeus species of African green monkeys (AGMs) to pigtailed macaques (PTMs

64 A group of 10 rhesus macaques (RMs) and 10 African green monkeys (AGMs) was exposed to aerosolized

65 Caribbean-born African green monkeys (AGMs) were classified as Chloroce

66 hoid organs from chronically SIVagm-infected African green monkeys (AGMs) were frequently CXCR5(+) an

67 A small number of African green monkeys (AGMs) were introduced into the Ca

68 ation in the respiratory tracts of hamsters, African green monkeys (AGMs), and chimpanzees.

69 cted predominantly in sooty mangabeys (SMs), African green monkeys (AGMs), and mandrills.

70 cted predominantly in sooty mangabeys (SMs), African green monkeys (AGMs), and mandrills.

71 by simian immunodeficiency virus SIVagm from African green monkeys (AGMs), do not encode Vpu.

72 In African green monkeys (AGMs), rHPIV1-P(C-) was considera

73 immunodeficiency virus (SIV) hosts, such as African green monkeys (AGMs), sustain nonpathogenic SIV

74 Unlike HIV-1-infected humans, African green monkeys (AGMs), the natural SIV host speci

75 nfected and uninfected natural hosts of SIV, African green monkeys (AGMs), to that of RMs.

76 er several days, in the respiratory tract of African green monkeys (AGMs).

77 ne strains were tested for immunogenicity in African green monkeys (AGMs).

78 beta induction and replicated efficiently in African green monkeys (AGMs).

79 nsitive and attenuated in mice, ferrets, and African green monkeys (AGMs).

80 e of acute and chronic SIVagm replication in African green monkeys (AGMs).

81 African green monkeys (AGMs; genus Chlorocebus) are a na

82 ailed macaques [PTMs]) and nonpathogenic (in African green monkeys [AGMs]) SIVsab infections to asses

83 m neutralizing antibody titers obtained from African green monkeys and after human vaccination and na

84 we demonstrate that nonhuman primates (NHPs; African green monkeys and cynomolgus macaques) harbor se

85 We identified multiple SAMHD1 haplotypes in African Green Monkeys and find that the vpr gene from di

86 ral SIV hosts (for example, sooty mangabeys, African green monkeys and mandrills) share many features

87 rence was used to disrupt CypA in cells from African green monkeys and rhesus macaques.

88 As the outcomes of SIVsab infection in PTMs, African green monkeys, and rhesus macaques are different

89 ost efficiently in the respiratory tracts of African green monkeys, and the infected animals develope

90 in the TRIM5alpha B30.2 domain v1 region of African green monkeys are also associated with broader a

91 unodeficiency virus (SIVagm) Vif can inhibit African green monkey but not human Apo3G.

92 A] were administered separately to groups of African green monkeys by the intranasal/intratracheal ro

93 African green monkeys can maintain long-term persistent

94 estricting activities expressed by human and African green monkey cell lines.

95 V(SYK) Vpr proteins are capable of arresting African green monkey cells but are completely inactive i

96 HuTRS1 (RhTRS1) fulfills these functions in African green monkey cells, but not rhesus or human cell

97 In African green monkey cells, HIV-1 virus-like particles a

98 IgA did not inhibit HAV infection of African green monkey cells, suggesting that the IgA and

99 CypA soon after entry into rhesus macaque or African green monkey cells, where, paradoxically, the in

100 attenuate Lv1 activity in rhesus macaque and African green monkey cells.

101 st activity could be demonstrated in cognate African green monkey cells.

102 African green monkeys (Cercopithecus aethiops sabaeus) w

103 Four African green monkeys (Cercopithecus aethiops) were inje

104 Herein we report that two species of African green monkeys (Chlorocebus sabaeus and C. pygery

105 0 lymphocyte-depleting antibodies to sabaeus African green monkeys (Chlorocebus sabaeus) before chall

106 ke gammaherpesviruses recently identified in African green monkeys, Chlorocebus rhadinovirus types 1

107 An African green monkey CMV UL32 homolog complemented Delta

108 exhibited a range of restriction in mice and African green monkeys comparable with that of two attenu

109 gene induction in LNCaP cells as well as in African green monkey CV-1 cells.

110 Infection of African green monkey CV1 cells with SV40 resulted in the

111 IVcpz [from chimpanzees] and SIVagmSab [from African green monkeys]) discordantly in different region

112 ha variants from humans, rhesus monkeys, and African green monkeys displayed different but overlappin

113 Here we show that many CD4(+) T cells from African green monkeys downregulate CD4 in vivo as they e

114 nary artery atherosclerosis were examined in African green monkeys fed diets containing cholesterol a

115 We immunised eight African green monkeys, four with a single dose of BHPIV3

116 residue 128, previously shown to distinguish African green monkey from human APOBEC3G.

117 reviously shown that intranasal SV protected African green monkeys from challenge with the related hu

118 arteriviruses (family Arteriviridae) in wild African green monkeys from Zambia (malbroucks [Chloroceb

119 Here, we discover two new viruses in African green monkeys from Zambia and South Africa.

120 African green monkeys (genus Chlorocebus) can be infecte

121 In African green monkeys immunized intranasally and intratr

122 African green monkeys immunized through the respiratory

123 African green monkeys immunized with b/h PIV3 expressing

124 We evaluated the immunological responses of African green monkeys immunized with multiple F and G pr

125 African green monkeys immunized with two doses of the ve

126 NDV-HA was administered to African green monkeys in two doses of 2 x 10(7) infectio

127 ttenuated/nonprogressive infection) and from African green monkeys infected with SIVsab9315BR (nonpat

128 r the onset of clinical anthrax disease, the African green monkey is a suitable animal model exhibiti

129 two attenuated viruses adapted to growth in African green monkey kidney (AGMK) and MRC-5 cells, resp

130 unknown natural function which serves as an African green monkey kidney (AGMK) cell receptor for HAV

131 Serum-starved primary African green monkey kidney (AGMK) cells also showed dec

132 clonal antibodies raised against susceptible African green monkey kidney (AGMK) cells as probes.

133 s isolated from a cDNA expression library of African green monkey kidney (AGMK) cells by using protec

134 Hepatitis A virus (HAV) infects African green monkey kidney (AGMK) cells via the HAV cel

135 V cellular receptor 1 (havcr-1) and protects African green monkey kidney (AGMK) clone GL37 cells (GL3

136 To characterize interactions between African green monkey kidney (BS-C-1) cell proteins and t

137 (HAV), HM175/P16, enhance growth in cultured African green monkey kidney (BS-C-1) cells but not in fe

138 Lytic infection of African green monkey kidney (CV-1) cells by simian virus

139 ase cDNA and establishing stably transfected African green monkey kidney (CV1) cell lines expressing

140 We found that the infection of African green monkey kidney (Vero) cells by vesicular st

141 ed cells, and produced very small plaques on African green monkey kidney (Vero) cells that were simil

142 H1N1, H3N2, H5N1 and H7N9 vaccine viruses in African green monkey kidney and Madin-Darby canine kidne

143 mma, inhibited vaccinia virus replication in African green monkey kidney BSC-40 cells.

144 xpansions and deletions were monitored in an African green monkey kidney cell culture system (COS-7 c

145 Preliminary studies indicated that an African green monkey kidney cell line (Vero) is a suitab

146 ed viral rescue and growth properties in the African green monkey kidney cell line, Vero.

147 he virus within a few cycles of infection in African green monkey kidney cell lines CV-1, CV-1P, TC-7

148 process generates H2O2, was introduced into African green monkey kidney cells (CV-1 cells) under the

149 ges in cell homeostasis were investigated in African green monkey kidney cells (CV-1) by assessing th

150 ytes, Kv1.3, was heterologously expressed in African Green Monkey kidney cells (CV-1) using a vaccini

151 AM, human U937 cells (histiocytic lymphoma), African green monkey kidney cells (MARC-145 and Vero), p

152 omes were microsurgically removed from BSC-1 African green monkey kidney cells before the completion

153 African green monkey kidney cells expressing pIgR demons

154 Hepatitis A virus (HAV) infects African green monkey kidney cells via HAV cellular recep

155 us following passage in C6/36 cells, primary African green monkey kidney cells, or Vero cells.

156 African green monkey kidney cells, Vero C1008, polarizab

157 urine melanoma cell line but not to the CV-1 African green monkey kidney cells, which express CD44 at

158 cap-independent viral translation in vivo in African green monkey kidney cells.

159 toma c37 cells and CYP1A1- and AHR-deficient African green monkey kidney CV-1 cells.

160 ty of their respective intracellular niches, African green monkey kidney epithelial (Vero) cells, A/J

161 inoculation was detected in only six: three African green monkey kidney epithelial cell lines (Vero,

162 ibit SV40 DNA replication in infected BSC-1 (African green monkey kidney epithelial) cells, albeit at

163 sseriae interact with CD66a-transfected COS (African green monkey kidney) and CHO (Chinese hamster ov

164 COS7 (African Green Monkey kidney) cells stably transfected wi

165 Using COS (African green monkey kidney) cells transfected with cDNA

166 lly active in 293T (embryonic kidney), Vero (African-green monkey kidney epithelial), 3T12 (mouse fib

167 rimate ACAT2 gene product was cloned from an African green monkey liver cDNA library.

168 four different species of naturally infected African green monkeys living in different regions across

169 V-1 cDNA, complete suppression of macaque or African green monkey Lv1 was achieved by the additive ef

170 eceptor CXCR6 by SIVagmSab to infect sabaeus African green monkey lymphocytes.

171 ecies of natural SIV hosts (sooty mangabeys, African green monkeys, mandrills, sun-tailed monkeys, an

172 Eleven fetal African green monkey midbrains were immunostained for ty

173 validated the use of RSV (Memphis 37) in an African green monkey model of intranasal infection and i

174 or G (PIV5/G) protein in the cotton rat and African green monkey models for their replication, immun

175 Adult African green monkeys naturally have low numbers of CD4

176 The recombinant viruses were administered to African green monkeys (NDV-BC and NDV-LS) and rhesus mon

177 The infecting SFV originated from an African green monkey (one person) and baboons (three peo

178 African green monkeys, one natural host species, avoid s

179 We describe a genome reference of the African green monkey or vervet (Chlorocebus aethiops).

180 ll samples from a human infected with SFV of African green monkey origin (SFV-3).

181 xpression of endogenous CRF1 in COS-7 cells (African green monkey origin).

182 sphorylation, RhTRS1 binds to phosphorylated African green monkey PKR.

183 irus has adapted to the polymorphisms of the African Green Monkey population in which it is found.

184 T) was characterized in plasma from infected African Green monkeys, rabbits, and guinea pigs.

185 transfection and deletion analysis in BSC-1 (African green monkey, renal epithelial) cells revealed t

186 primary cells or established cell lines from African green monkey, rhesus macaque, and baboon.

187 hepatitis after intravenous inoculation into African green monkeys, rhesus monkeys, and marmosets.

188 proteins; the human and, to a low level, the African green monkey sequences bound soluble HCV E2 (sE2

189 most cleavage-efficient mutant, R-R-R-R, in African green monkeys showed that there was no detectabl

190 We now report a novel function of African green monkey simian immunodeficiency virus (SIVa

191 n target only human Apo3G (hApo3G), whereas, African green monkey simian immunodeficiency virus (SIVa

192 Both Vif proteins of HIV-1 and African green monkey simian immunodeficiency virus (SIVa

193 bey (simian immunodeficiency virus SIV(SM)), African green monkey (SIV(AGM)), and Sykes' monkey (SIV(

194 imian immunodeficiency viruses isolated from African green monkeys (SIVagm) contain a single accessor

195 an immunodeficiency virus (SIV) that infects African green monkeys (SIVagm) contains a vpr homologue,

196 Simian immunodeficiency virus from African green monkeys (SIVagm) results in asymptomatic i

197 during nonpathogenic infection with SIV from African green monkeys (SIVagm), follicles remain general

198 HIV-2 and simian immunodeficiency virus from African green monkeys (SIVagm), in one round of viral re

199 (HIV-1) and simian immunodeficiency virus of African green monkeys (SIVagm).

200 of HIV-1 itself, HIV-2 and SIV isolated from African green monkeys (SIVAGM).

201 , which infects rhesus macaques (SIVmac) and African green monkeys (SIVagm).

202 an HIV-1 (simian immunodeficiency virus from African green monkeys [SIVagm] and Rhesus macaques [SIVm

203 estricted infection by SIVmac and the SIV of African green monkeys, SIVagm.

204 he red-capped mangabey (SIVrcm), the sabaeus African green monkey (SIVagmSAB), and the chimpanzee (SI

205 an immunodeficiency virus (SIV) that infects African green monkeys (SIVagmTAN), unlike human Apobec3D

206 gm infection in its sabaeus monkey host, the African green monkey species endemic to West Africa.

207 r HT) gene into a demyelinated lesion of the African green monkey spinal cord.

208 assays developed to measure SIVagm from two African green monkey subspecies demonstrated high levels

209 correlated with that previously observed for African green monkeys, suggesting that the HAE model has

210 African green monkeys systemically immunized with HPV-11

211 on the CD4(+) T cells of young mandrills and African green monkeys than on those of adults, we propos

212 boost RSV neutralization antibody titers in African green monkeys that had been infected previously.

213 Here we show in African green monkeys that systemic delivery of an anti-

214 e enzyme activities were measured in rat and African green monkey tissues.

215 In this study, we exposed African green monkeys to B. anthracis spores; examined c

216 Here, we compared the plasma virome of West African green monkeys to that in their descendants after

217 Sixteen St. Kitts African green monkeys treated with 1-methyl-4-phenyl-1,2

218 Previously, we have shown that African green monkey TRIM5alpha (AgmTRIM5alpha) potently

219 We created a panel of African green monkey TRIM5alpha (TRIM5alpha(AGM)) mutant

220 by at least two different retroviruses, and African green monkey TRIM5alpha was able to inhibit infe

221 In African green monkeys, vaccine-induced serum and mucosal

222 ls and human foreskin fibroblasts but not in African green monkey (Vero) cells.

223 It was found that all vaccinated African green monkeys were completely protected against

224 HMPV-infected chimpanzees and African green monkeys were highly protected from challen

225 y and protective efficacy in cotton rats and African green monkeys, which are among the best availabl

226 virus (HAV) was originally isolated from an African green monkey with hepatitis and appears to repre

227 We infected 35 Asian macaques and African green monkeys with viruses that do or do not exp